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Background: Cytolytic effector cells of the immune 
system recognize and lyse cells that carry non-self epitopes. 
One mechanism of cell lysis involves release of a 67-kDa 
pore-forming protein, perforin. The amino-terminal 
domain of perforin (2 19 residues) can account for most 
of the lysis activity, by a mechanism that is similar to that 
of holoperforin. Detailed mechanistic studies of this 
domain should yield useful insight into the factors 
underlying perforin activity in vim. 
Results: The mechanism of pore formation by the 22- 
residue amino-terminal domain of perforin was studied 
by kinetic and thermodynamic methods. Approximately 
4 * 1 peptide monomers form an active pore by a 
mechanism that displays negative cooperativity. 
Conclusions: A negatively-regulated aggregation mech- 
anism is likely to be common for pore-forming peptides. 
The positively-charged domain B of perforin (residues 
7-15) may mediate cooperativity through electrostatic 
interactions. Such a mechanism limits the number of 
protein molecules that are committed to any particular 
channel. This data supports smaller pores as the physio- 
logically relevant aggregate, rather than the larger ring 
sizes identified by electron microscopy at higher, 
non-biological concentrations. 
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Introduction 
Cytotoxic T lymphocytes (CTL) are effector cells of the 
immune system that recognize and lyse target cells 
carrying non-self epitopes [1,2]. CTL’s appear to 
mediate cell lysis by two distinct pathways (Fig. 1). The 
first pathway results in the release of perforin, a 67-kDa 
pore-forming protein that shows significant homology 
to the ninth component (C9) of human complement 
[3]; the second involves surface-bound Fas ligands and 
receptors [2,4,5]. Recent investigations have demon- 
strated that most of the lysis activity of human (or 
murine) perforin can be accounted for by a 19-residue 
amino-terminal peptide, by a mechanism that is similar 
to that of holoperforin [6,7]. Detailed structural and 
mechanistic studies of this domain should therefore 
yield useful insight into the factors underlying perforin 
activity in r&o. The studies reported here address the 
mechanism of pore formation by the 22-residue amino- 
terminal domain of perforin (PZ2), which includes the 
tryptophan residue at position 21 as a fluorescent probe 
[8]. We have found that the amino-terminal peptide 
mediates lysis of a target membrane by a mechanism 
that exhibits a high degree of negative cooperativity. 
Peptide binding was analyzed in terms of a model that 
incorporates non-ideal interactions and aggregation in a 
membrane bilayer. The minimum number of peptide 
monomers required to form an active pore was esti- 
mated to be -4 & 1. Negative regulation of pore forma- 
tion is likely to be mediated by a positively-charged 
sequence of residues in the amino-terminal domain. 
Positively cooperative binding phenomena are more 
commonly observed in biological chemistry and range 
from the well characterized example of dioxygen 
binding to hemoglobin, to the stacking of nucleotide 
bases and the formation of aggregates of indefinite size 
[9]. Negative cooperativity is characterized by those cases 
where binding of a ligand to a protein decreases the 
affinity of the protein for other ligands of the same or a 
different type. For example, negative cooperativity is 
observed in the binding of aspartates to aspartate recep- 
tors [lo]. Binding of the first aspartate induces a change 
of conformation that diminishes the affinity for binding 
of a second ligand. Negative cooperativity is also 
observed in the binding of nucleotides by helicase Dna B 
[ll]. In our case, negative cooperativity is observed 
during the peptide aggregation step of pore formation, 
where the ligand is an additional peptide molecule, and 
electrostatic interactions among these peptides appear to 
limit the size of the pore. 
Results and discussion 
Assembly of the active pore complex was assayed spec- 
trophotometrically by monitoring the release of car- 
boxyfluorescein (CF) from synthetic vesicles composed 
of phosphatidylcholine (PC) and cholesterol (1:l) (Figs 2,3) 
[6]. Since the size and uniformity of vesicle preparations 
are important factors that influence the rate of CF release 
[12], we have prepared uniform small unilamellar vesicles 
by use of a sonication method [13]. This method pro- 
vides small homogeneous vesicles with diameters of 
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Fig. 1. Summary of CTL-mediated pathways. After binding of the 
major histocompatibility complex (MHC) to the T-cell receptor 
(TCR), perforin is released from the T-cell, and/or Fas ligand is 
expressed. The latter may form a complex with the Fas receptor 
(FasR) on the target cell membrane to initiate an apoptotic response. 
-40 & 10 nm, as determined by electron microscopy, 
although the encapsulation efficiency is reduced as a 
consequence of the smaller internal volume. 
Kinetic data were analyzed in terms of a model that des- 
cribes pore formation as a two-step process: partitioning 
of the peptide into the membrane, followed by aggrega- 
tion to form a functional pore [14,15]. The kinetic 
scheme can be described by the following equations: 
fast 
A,+L = A1 
mAl -R (2) 
where A, is the free aqueous peptide, A, is the monomeric, 
lipid-associated peptide, L is a lipid membrane, and m is 
the number of peptide monomers that form a pore R. 
Release of carboxyfluorescein is diffusion-controlled once 
the pore is formed. Since the lifetime of the pore is 
longer than the time necessary for complete diffusive 
efflux of the dye (as estimated from Fick’s law), pore for- 
mation meets the requirement for complete release of the 
lye. The first step, which involves partitioning of the 
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Fig. 2. Schematic illustration of the assay for monitoring pore forma- 
tion using carboxyfluorescein filled vesicles. (a) The concentrated 
dye solution (80 mM) shows weak fluorescence as a result of self- 
quenching. (b) After addition of the peptide, a pore is formed 
and carboxyfluorescein is rapidly released from the vesicle. Upon 
dilution of carboxyfluorescein, the fluorescence intensity increases. 
monomeric peptide inside the membrane, is very f&t for 
the pore-forming peptide melittin (1.4 x 10” M-’ s--l) 
[16]. Since the time taken for the first step of pore forma- 
tion by P,, is likely to be similar to that taken by melittin, 
partitioGg of Pz2 should be complete in seconds. The 
time required for lysis is on the order of minutes; we asso- 
ciate this slow rate with the P,, aggregation step after 
membrane insertion. An alternative mechanism, where 
the peptide simply serves to disrupt the membrane 
without pore formation, is inconsistent with the slow rate 
of release of CE 
Within the framework of this model, the measure p(t), 
the average number of pores per vesicle at time t, can be 
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Fig. 3. Steady-state kinetic traces of pore formation. (a) Time 
trace showing the change in fluorescence intensity as a function 
of peptide concentration (0.22, 0.44, 0.55, 1 .OO, 2.21, 3.32, 8.3 
and 11 .O PM) after mixing with carboxyfluorescein-entrapped 
vesicles (phosphatidylcholine:cholesterol, 1 :l, lipid concentra- 
tion 1 mM). For the data shown, a pH gradient (pHinside=5.0, 
pHoutside = 7.0) was used to accentuate the change in carboxyflu- 
orescein emission. The upper dashed line corresponds to the lim- 
iting (FJ value obtained after addition of Triton X-l 00 (0.02 % 
final concentration). The background rate of CF release in the 
absence of P,, is indicated by the lower dashed line. (b) Plot of 
p(t), the average number of pores per vesicle at time t, versus 
time, for peptide and lipid concentrations of 11 FM and 1 mM, 
respectively. The solid curve through the data was calculated 
according to equation 4. 
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related to the change in carboxyfluorescein emission 
using equation 3 [ 141, 
p(t) = -In (F,-F(t))/(F_-F,,) (3) 
where F(t) is the observed fluorescence intensity at 
time t, F, is the final limiting fluorescence, and F,, is 
the initial fluorescence of the intact vesicles. Figure 3b 
shows the plot of p(t) versus time.The rate profile for 
association decreases from an initial fast rate (vpo) that 
is limited only by the rate of pore formation, to an 
intermediate value (v,~) that results in a steady-state 
release of carboxyfluorescein. The latter results from a 
variety of factors that include the size distribution of 
the vesicles, inactivation of pore formation with time, 
and possibly rate-limiting dissociation and re-employ- 
merit of the peptide. A correction that accounts for the 
size distribution of vesicles can be applied to the p(t) 
function; however, both this, and the other factors just 
which is used to determine the initial velocity vpo 
[14,15]. For th. is reason they can be reasonably ne- 
glected for this analysis. The kinetic profile shown in 
Figure 3 can be fit to equation 4 [ 141, with a time 
constant (k). 
p(t) = vpi t + (v,(,-vpi)[(l -e@)/k] (4) 
Figure 4a shows the result of a Hill analysis of the initial 
rate (vpo) [17]. A fit to the linear portion of the plot gave 
a Hill coefficient h = 0.72 + 0.08, indicative of negative 
cooperativity. In Figure 4b, a plot of l/vpO versus l/[P,,] 
shows a concave-down profile, again characteristic -of 
negative cooperativity [17]. These data were obtained 
with a pH gradient (pHinslde=5.0, pHoutside=7.0) to 
accentuate the change in carboxyfluorescein emission. 
Negative cooperativity was also observed in the absence 
of a gradient (pHinside = 7.0, pHoutside = 7.0), although the 
change in emission was smaller and the errors were 
detailed, are negligible in the early stages of the plot, greater (Figs. 4c,d). 
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Fig. 4. A Hill analysis indicates negative cooperativity. (a) The results of a Hill analysis of the initial rate data for peptide-mediated release 
of carboxyfluorescein from lipid vesicles (experimental conditions as described in the legend to Fig. 3), and (b) the variation of l/vp, 
versus l/[P,,l. The value of vpOmax was calculated from the intercept of a plot of l/v,o, vs l/[peptide],, [17]. A Hill coefficient h=0.72 was 
obtained. These results were confirmed by independent monitoring of the change In fluorescence intensity of the tryptophan residue 
accompanying binding and pore formation. Titrations were carried out both by adding vesicles to a solution of peptide, and by adding 
increasing amounts of peptide to a solution of vesicles. For comparison, (c) and (d) show the results of a similar Hill analysis for data 
obtained in the absence of a pH gradient (pHinSide= 7.0, pHoutside = 7.0). A Hill coefficient h =0.9 was obtained. 
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Fig. 5. Evaluation of the number of peptide monomers required 
to form an active pore. (a) Increase of the tryptophan fluores- 
cence (l/l,) at 355 nm for 17 ~J,M peptide upon titration with lipid 
vesicles (phosphatidylcholine:cholesterol, 1 :I, lipid concentra- 
tion between 34 )LM and 1.4 mM) in Hepes buffer (10 mM) with 
NaCl (150 mM) at 25 “C. Data were obtained in the absence of a 
pH gradient (pHinside= 7.0, pHoutside= 7.0). Fluorescence intensi- 
ties were corrected using the vesicle blank. The upper dashed 
line corresponds to the limiting value of l/l, calculated from 
double-reciprocal plots according to standard procedures 
[18,19]. (b) Plot of the degree of incorporation of the peptide (r) 
versus free peptide concentration (C,,). The solid line shows a fit 
of the data at high r values to equation 5 (with C r* = 2.0 ~.LM and 
z = 1.5), and the dashed line corresponds to a It of the data at P 
low r values to equation 6, which accommodates cooperativity 
(with Cr,,*=2.0~M, z=1.5, B=20, and m=4). 
Supporting evidence for negative cooperativity was also 
obtained from thermodynamic binding studies by moni- 
toring the intrinsic fluorescence of tryptophan 21 (Fig. 
5a). Fitting the binding data by a simple Hill analysis pro- 
vided a coefficient h = 0.8 t 0.1. In addition, cooperativ- 
ity is clearly demonstrated by the analysis of these data 
shown in Figure 5b and discussed below. 
To obtain a more representative view of pore formation, a 
model (shown schematically in Fig. 6) that includes 
monomer partitioning, aggregation, and thermodynamic 
non-ideality was considered [ 18,191. This model assumes 
(a) 6) 
Fig. 6. Three key steps to pore formation. (a) The peptide concen- 
tration must reach a critical level C,,r* before significant partition- 
ing into the lipid membrane (b) and aggregation (c) can occur. At 
this point the partition constant, T (a type of equilibrium constant) 
defines the relative concentration of free (C,,) and membrane- 
associated (C,,) peptide. Subsequently, m peptrde monomers 
aggregate in a rate-limiting step (rls) to form an active pore (c). The 
aggregation occurs in a negatively cooperative manner. 
that there is no aggregation of the peptide in the aqueous 
phase. This assumption is justified by results from NMR 
experiments, which show no evidence for peptide aggre- 
gation even at higher concentrations than those used in 
these studies. Figure 5a shows the increase of the Trp 
fluorescence intensity ratio I/I0 at 355 nm upon titration 
with lipid vesicles, where I is the observed fluorescence 
intensity, and I, is the control intensity in the absence of 
lipid. The total concentration of peptide (Cl,) is equal 
to the sum of the free peptide concentratron (C,,J 
and the lipid-associated peptide concentration (C,,) (Fig. 
6), while the extent of incorporation (r) is equal to 
C&/C, where Cl is the lipid concentration. The mag- 
nitudes of r and C,, were calculated by standard proce- 
dures [16,18,19], and the extent of association defined by 
a plot of r versus $-is shown in Figure 5b.The initial lag 
phase and subsequent upward turn are again characteristic 
of a cooperative process ]I 91. 
Assuming a two-state model, the fluorescence intensity 
ratio is proportional to r through the relationship 
I/I,= (I/I,)_ .r.C,/C .The 
is consistent with t e model illustrated in Figure 6, K 
shape of the plot in Figure 5b 
involving the partitioning of monomeric peptide, fol- 
lowed by aggregation within the membrane. Simple 
binding would result in a straight line plot of r versus 
C pp rather than the curve that is actually observed, with 
an early lag phase and subsequent rise after the critical 
free peptide concentration, Cpf”, is reached [ 18,191. This 
mechanistic model has been successful in rationalizing 
the behavior of a number of peptides, including 
paradaxin 1201 and the cx5 segment of 6-endotoxin [21]. 
The partition coeffkient, which provides a measure of 
the affinity of the peptide for the membrane, was calcu- 
lated for the monomeric peptide P,, (r = 1 O3 M-‘) from 
the very beginning of the lag phase, with the extent of 
incorporation of the monomeric peptide defined by 
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Fig. 7. Domain structure of the perforin peptide. Electrostatic 
repulsion between multiple copies of the positively charged 
central domain B may be responsible for the negative cooperativity 
associated with pore formation. 
r, = rlCpi.This value is of the same order of magnitude 
as the partition coefficient of the channel-forming 
alamethicin peptide (r = lo3 M-l) [18], but is one order 
of magnitude smaller than the coeffkient for melittin 
(l- = 3 xlO”M-‘) [16], a strong surface-binding peptide. 
A sharp upwards turn is observed at the critical concen- 
tration Cpi*, at which the peptide aggregates in the 
membrane. For larger values of r (> 0.05), corresponding 
to [P2*1 ’ c 
8 
;, essentially all of the incorporated peptide 
is aggregate . Under these conditions, equation 5 holds 
[I 81, where z is a numerical constant. 
C,,= (1 + 2r)“Cpi* (5) 
A fit of our data to this equation for values of r > 0.1 
provides a value of 2.0 PM for CpF and 1.5 for z. This 
model does not, however, fit the lag part of the curve 
(Fig. 5b).At peptide concentrations that are less than the 
critical concentration C i* ([Pzz] < 2 PM), equation 6 is 
appropriate [ 181, where 6 IS an equilibrium constant that 
relates to addition of a membrane-bound monomer to 
the aggregate, s = (C,+C i*)/(l 
number of monomers that orm a pore [18]. Satisfactory f 
+ 2r)Z and m is the 
fits were obtained when m was in the range of 3 to 5. 
Br = s[l + {(m(l - s) + s)s(“‘-I)/(1 - s)~}] (6) 
This model assumes an isodesmic aggregation, where 
each aggregation step is assumed to have the same equi- 
librium constant B. While other models can be used, the 
resulting fit to the data shows no difference in compari- 
son to the isodesmic model. The fit to the data with 
equation 6 provides reasonable parameters and lends 
credence to the model. 
It is important to note that this data supports a previous 
proposal that smaller pores are the physiologically rele- 
vant aggregate in perforin-mediated target cell lysis [2], 
rather than the larger ring sizes that have been identified 
by electron microscopy. The latter data are obtained 
under conditions of higher concentration that may not 
be relevant in a biological context. 
The primary sequence of the peptide suggests a func- 
tional model whereby the strongly positively charged 
domain B (residues 7-15; Fig. 7) may negatively regulate 
cooperativity though electrostatic interactions among the 
charged sidechains.This is supported by the lower COOP- 
erativity observed at moderately higher pH (Fig. 4c,d). 
Such a model is open to experimental testing and studies 
of this nature are currently underway in our laboratory. 
Significance 
We have demonstrated a significant level of neg- 
ative cooperativity in peptide aggregation and 
pore formation for the lytic amino-terminal 
domain of perforin. To our knowledge there 
have been no prior reports of negative coopera- 
tivity in pore formation by such peptides. 
However, a negatively-regulated aggregation 
mechanism is likely to be common for pore- 
forming peptides, and is reasonable in view of 
the functional requirements of the perforin 
protein, providing a mechanism to limit the 
number of protein molecules that are commit- 
ted to any particular channel. These data also 
support the notion that a small pore size is the 
physiologically relevant aggregate in perforin- 
mediated cell lysis, not the larger ring sizes 
identified by electron microscopy at higher, 
non-biological, concentrations of perforin [2]. 
Materials and methods 
Peptide synthesis and modification 
The 22-residue peptide was prepared by automated synthesis 
in The Ohio State Biochemical Instrument Center on a 
Beckman F30X peptide synthesizer, and purified by HPLC 
using a Dynamax Cl8 column.The resulting peptide was iso- 
lated as a single band with no evidence of impurities in high 
resolution ‘H-NMR spectra. 
Preparation of vesicles 
Small unilamellar carboxyfluorescein-entrapped vesicles 
(phosphatidylcholine:cholesterol, 1 :l) were prepared by a 
sonication method according to published procedures 
[13,22]. All procedures were performed under argon at 
ambient temperature, unless stated otherwise. Egg phos- 
phatidylcholine (Sigma) and cholesterol (Sigma) were mixed 
in a 1: 1 rtoichiometry in chloroform and the solvent 
removed under vacuum by rotary evaporation. The lipids 
were resuspended to 1.5 mM in buffer (80 mM carboxyfluo- 
rescein, 10 mM Hepes, pH 7.0, 150 mM NaCl) by vortex 
nuxmg, and the resultant lipid dispersion was sonicated for 
30 min in a bath type sonicator, and then for 30 min with a 
probe sonicator (4-mm tip diameter at 20 ‘%I power). Metallic 
debris from the titanium head was removed by centrifuga- 
tion. Unencapsulated CF was removed by passing the vesicle 
solution through a Sephadex G-50 column.The lipid con- 
centration of the solution was determined by phosphorus 
analysis [23].All vesicle solutions were freshly prepared before 
each experiment. Negative stain electron microscopy demon- 
strated the vesicles to be unilamellar with a diameter in the 
range of 40 i 10 nm (-60 76 had diameters of 40 nm). 
Fluorescence measurements 
Steady state fluorescence measurements were made on a Perkin 
Elmer luminescence spectrometer, model LSSOB. 
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Carboxyfluorescein release 
A vesicle solution was mixed with a solution of peptide at 
25 “C.The reaction buffer contained 10 mM Hepes (pH 7.0) 
and 150 mM NaCl. For some experiments a pH gradient was 
used in order to accentuate the amplitude of the spectral change 
from CF. The pH inside the vesicles was maintained at 5.0 with 
10 mM citrate buffer, and the outside pH was 7.0 (10 mM 
Hepes).The stability of the pH gradient was checked both by 
monitoring the absorbance of CF inside the vesicles (the 
absorbance spectrum of CF is highly pH sensitive) and by mea- 
suring the pH with a classical pH meter and microelectrode. 
The pH gradient and the vesicles were stable in the time frame 
of the experiment.The change in fluorescence signal from CF 
was monitored as a function of time. Instrument parameters 
were as follows: carboxytluorescein, X,, = 490 11111, X,,, = 520 nm; 
slitwidths for excitation and emission were set at 5 nm. The 
final limiting fluorescence (F_) corresponding to 100 %J release 
of carboxyfluorescein was determined by the addition ofTriton 
X-100 (0.02 % final concentration) to the cuvette.This destroys 
all the vesicles and corresponds to 100 % lysis. 
Titrations 
Titrations were performed by adding increasing amounts of con- 
centrated vesicle solution to peptide solutions containing 6 FM, 
10 FM, 12 PM, and 17 PM peptide.The fluorescence of the tryp- 
tophan residue was monitored at equilibrium with A,,-295mn, 
A ,,,-355 nm, and slitwidths of 5 nm for excitation and 10 nm 
for emission. The contribution of lipid vesicles was 
independently determined and subtracted from the titration data. 
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